“Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study” (2025) International Journal of Public Research in Medicine and Health, 1(1), pp. 10–19. doi:10.66328/ijprmh.2025.010103.